auroushealthcare.wordpress.com
EMA recommends conditional marketing authorisation for Translarna to treat Duchenne muscular dystrophy
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a conditional marketing authorisation for Translarna (ataluren), an orphan-designated …